Abraxane and Metastases to bone - a phase IV clinical study of FDA data
Summary:
Metastases to bone is reported as a side effect among people who take Abraxane (paclitaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have Pain.
The phase IV clinical study analyzes which people have Metastases to bone when taking Abraxane. It is created by eHealthMe based on reports of 19,123 people who have side effects when taking Abraxane from the FDA, and is updated regularly.
What is Abraxane?
Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.
What is Metastases to bone?
Metastases to bone (cancer spreads to bone) is found to be associated with 1,139 drugs and 899 conditions by eHealthMe. Check the latest studies of Metastases to bone.
19,123 people reported to have side effects when taking Abraxane.
Among them, 348 people (1.82%) have Metastases to bone.

Among these 348 people:
How long have people been on Abraxane when they have Metastases to bone? *
What is the gender of people who have Metastases to bone when taking Abraxane? *
What is the age of people who have Metastases to bone when taking Abraxane? *
What are other drugs people take besides Abraxane? *
What are other side effects people have besides Metastases to bone? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abraxane and have Metastases to bone?
- Check whether Metastases to bone is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abraxane:
- Abraxane (19,196 reports)
Metastases to bone treatments and more:
- Metastases to bone (51,059 reports)
How severe was Metastases to bone and when was it recovered:
Expand to all the drugs that have ingredients of paclitaxel:
- Metastases to bone and drugs with ingredients of paclitaxel (1,921 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abraxane:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Metastases to bone:
- Metastases to bone (1,139 drugs)
Browse all the conditions that are associated with Metastases to bone:
- Metastases to bone (899 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Abraxane) and Abraxane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Etodolac cause Nephrogenic Anaemia? - 5 seconds ago
- Could Cabergoline cause Hypokalemia? - 8 seconds ago
- Could Etodolac cause Lymph Follicular Hypertrophy? - 10 seconds ago
- Drug interactions of Modafinil and Aimovig - 11 seconds ago
- Could Etodolac cause Heart Rate Increased? - 16 seconds ago
- Drug interactions of Tofacitinib Citrate and Apremilast - 21 seconds ago
- Could Etodolac cause Jaundice - Yellow Skin? - 22 seconds ago
- Could Orgovyx cause Erection Problems? - 24 seconds ago
- Could Orgaran cause Tumor Lysis Syndrome? - 26 seconds ago
- Could Byetta cause Photophobia? - 30 seconds ago